Marshall Wace, LLP Harpoon Therapeutics, Inc. Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.78 - $5.02 $127,702 - $360,149	71,743 New	71,743 $137,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.08 $833,666 - $1.9 Million	-235,499 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.69 - $7.83 $1.34 Million - $1.84 Million	235,499 New	235,499 $1.78 Million
Q4 2020 Feb 16, 2021	SELL	$12.83 - $17.84 $671,624 - $933,888	-52,348 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$11.01 - $18.52 $576,351 - $969,484	52,348 New	52,348 $889,000
Q4 2019 Feb 14, 2020	SELL	$12.94 - $20.58 $35,585 - $56,594	-2,750 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.93 - $17.47 $30,057 - $48,042	2,750 New	2,750 $38,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.